Marcus Semones

Dr. Semones was a member of Faculty at Harvard University, Department of Chemistry and X-Ray Crystallography before founding the Company in 2015. Pioneering research in the Harvard University Physics Dept. provided the foundation for WaveGuide’s breakthrough portable NMR platform. Dr. Semones secured the exclusive license from Harvard University across fields of use including medical diagnostics, pharmaceutical, food, oil & gas, through to emerging markets such as THC/cannabis legal production and roadside detection. He has 25 publications in respected journals such as JACS (Journal of American Chemical Society) and JOC (Journal of Organic Chemistry). Dr. Semones is listed on five patents in the biotechnology field.

Dr. Semones received his Ph.D. in Organic Chemistry from Emory University under Professor Albert Padwa. Independently researched synthetic methodology and natural product synthesis. Developed a novel 1,4-dipolar cycloaddition reaction for the stereo-controlled synthesis of complex aza, diaze, and polyaza-heterocyclic ring systems. Following his Ph.D. he went on to Harvard University with a Post-Doc assignment under Professor Yoshito Kishi in the Department of Chemistry.

A decade of experience gathered in industry with GlaxoSmithKline (GSK) Pharmaceuticals as a Senior R&D Investigator Dr. Semones identified opportunities and participated in due diligence efforts for GlaxoSmithKline’s acquisition of several new technologies, secured pre-clinical assets, and in-licensed compounds from Kyowa Hakko Kirin for oncology programs.